We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ancillary Tests Developed for Salivary Gland Pathology

By LabMedica International staff writers
Posted on 03 May 2017
Print article
Image: An immunohistochemistry of fine needle aspirates in acinic cell carcinoma (AciCC) for SRY-related HMG-box 10 (SOX10) and 2-deoxyglucose-6-phosphate phosphatase (DOG1) (Photo courtesy of Emory University School of Medicine).
Image: An immunohistochemistry of fine needle aspirates in acinic cell carcinoma (AciCC) for SRY-related HMG-box 10 (SOX10) and 2-deoxyglucose-6-phosphate phosphatase (DOG1) (Photo courtesy of Emory University School of Medicine).
Salivary gland tumors represent a diverse set of tumors with a broad range of biologic behaviors, ranging from completely benign tumors to low-grade malignancies to high-grade malignancies.

In addition to this wide range in clinical behavior, salivary gland tumors can show extensive morphologic overlap, so much so that, in many cases, a definitive diagnosis can be impossible without examination of the entire tumor.

Pathologists at the Emory University School of Medicine have examined some of the new advances in salivary gland tumor pathology that have a potential for clinical impact. Ancillary testing with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are improving the ability to make specific diagnoses, or at least to limit the diagnostic consideration on biopsies.

The use of IHC and/or FISH testing can be helpful in the accurate diagnosis of salivary gland tumors in both large resections and, more important, in small biopsy specimens, when combined with clinical information and morphology. These tests are even more useful when applied as part of a panel approach that incorporates tumor morphology to limit the differential diagnosis. Salivary gland tumors also occasionally show targetable molecular alterations, and combined with more-accurate diagnosis, this may allow for more-tailored treatment for the patient and the particular tumor.

Specific tumor types show different frequencies of targetable pathways; therefore, ancillary testing should be tailored to the specific diagnosis. The continuation of clinical work will probably discover more characteristic chromosomal rearrangements, useful antibodies, and targetable mutations in these rare tumors. The study was published in the March 2017 issue of the journal Archives of Pathology & Laboratory Medicine.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.